GYRE vs XOM · rev $53.5M vs P/E 24, rev $201.16B
Gyre Therapeutics Inc. (GYRE) versus Exxon Mobil Corp (XOM) — a side-by-side from cached financials, not a winner call.
Gyre Therapeutics Inc. (GYRE) is a biotechnology company listed on NASDAQ.
Exxon Mobil Corp (XOM) is a oil & gas integrated company listed on NYSE. It is led by Darren W. Woods.
Latest reported GYRE revenue for 2026-06-30 was $53.5M. Net income was -$32.8M. GYRE currently screens at market cap $589.9M.
Latest reported XOM revenue for 2026-06-30 was $201.16B. Net income was $18.71B. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
GYRE currently screens at market cap $589.9M. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
Not investment advice. Open the GYRE and XOM stock pages for the full models.
Not investment advice.